Delivery Order SPE2DB20D1100-SPE2DB25FE0VK
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for $9,652.90 to supply Biktarvy 30-120-15 mg tablets (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- The Defense Logistics Agency awarded a $24,229.80 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $78,499.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,540.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract represents a non-competitive, non-set-aside award and carries an ultimate completion date of June 25, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,159.79 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed price, competitively awarded delivery order has an ultimate completion date of August 25, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count unit dose packaging). The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $6,394.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed price terms with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $92,395.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's established pharmaceutical distribution...
- AmerisourceBergen Drug Corp received a $13,077.88 delivery order from the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price contract, with an ultimate completion date of August 18, 2025, was awarded without a set-aside designation through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0VKDelivery Order
The Defense Logistics Agency awarded a $28,767.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order represents a child contract issued under a larger indefinite delivery contract vehicle. This delivery order falls under AmerisourceBergen's existing $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to federal health systems, including the Defense Health Agency, U.S. Coast Guard, and military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains through open and competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 9/23/25 |